St. Jude Medical (St. Paul, Minnesota) reported that an interim analysis of its FAME II trial has found highly statistically significant reduction in the need for hospital readmission and urgent revascularization when Fractional Flow Reserve (FFR)-guided assessment was used to direct treatment in patients with coronary artery disease.

Prometheus v. Mayo has had its day at the Supreme Court, but the Court has yet to render a verdict. This leaves everyone with a couple of months on their hands to speculate as to what the outcome might be. Let's take a quick look at some of the opinions that have been offered on this subject. In a Dec. 8 posting at IPWatchdog.com, attorney Ryan Chiromas of Westerman Hattori Daniels & Adrian (Washington) said he was “surprised at how little Bilski was mentioned,” a reference to the business method patents case that seemed to send the message that...